News & Updates
Filter by Specialty:
Comorbidities fewer prior to onset of giant cell arteritis
Patients with giant cell arteritis (GCA) have a lower prevalence of diabetes mellitus as well as median fasting blood glucose (FBG) and body mass index (BMI) up to 5 years prior to diagnosis, according to a study, indicating the influence of metabolic factors on the risk of GCA.
Comorbidities fewer prior to onset of giant cell arteritis
29 Apr 2023Dietary markers linked to depression, anxiety in adults with obesity
Dietary markers, such as animal protein intake, appear to contribute to depression and anxiety in individuals with comorbid obesity, reveals a study.
Dietary markers linked to depression, anxiety in adults with obesity
28 Apr 2023Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
Laser acupuncture, when combined with supplementation with calcium and fluoride-containing vitamin D, appears to increase forearm bone mineral density and reduce wrist pain in postmenopausal women with osteoporosis, according to the results of a randomized controlled trial.
Laser acupuncture plus vitamins beneficial in postmenopausal women with osteoporosis
28 Apr 2023SARS-CoV-2 infection poses heightened risk of diabetes
SARS-CoV-2 infection puts individuals at increased risk of developing diabetes, contributing to between 3 percent and 5 percent excess burden of diabetes at a population level, as reported in a study.
SARS-CoV-2 infection poses heightened risk of diabetes
26 Apr 2023Coordinated, multifaceted intervention improves uptake of cardiopreventive therapies in T2D
The implementation of a coordinated, multifaceted intervention helps increase the prescription of three groups of evidence-based cardiopreventive therapies in adults with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease, according to a study.
Coordinated, multifaceted intervention improves uptake of cardiopreventive therapies in T2D
25 Apr 2023NSAID use ups risk of heart failure in T2DM patients
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) tends to elevate the risk of first-time hospitalization for heart failure (HF) in patients with type 2 diabetes mellitus (T2DM), a study has shown. In addition, those with advanced age, elevated haemoglobin (Hb) A1c levels, and new users are particularly at higher risk.